Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

End-of-day quote. End-of-day quote  - 02/10
94.85 EUR   +1.80%
02/09DJSanofi Profit Hit By Falling Diabetes Revenue -- Update
02/09DJSanofi Profit Hit By Falling Diabetes Revenue
02/09 BAYER : Continues to Grow its Open Innovation Activities
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
02/04/2016 02/05/2016 02/08/2016 02/09/2016 02/10/2016 Date
98.47(c) 96.4(c) 94.51(c) 93.17(c) 94.85(c) Last
3 185 800 3 524 601 4 715 804 3 754 706 2 920 141 Volume
-0.07% -2.10% -1.96% -1.42% +1.80% Change
More quotes
Financials (€)
Sales 2015 46 521 M
EBIT 2015 7 812 M
Net income 2015 4 301 M
Debt 2015 19 008 M
Yield 2015 2,62%
Sales 2016 48 505 M
EBIT 2016 8 287 M
Net income 2016 5 268 M
Debt 2016 15 485 M
Yield 2016 2,89%
P/E ratio 2015 19,30
P/E ratio 2016 15,57
EV / Sales 2015 2,09x
EV / Sales 2016 1,94x
Capitalization 78 436 M
More Financials
Company
Bayer AG is engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials.It operates through the Healthcare, Crop Science and Material Science subgroups, which are supported by three service companies.The Healthcare subgroup... 
Sector
Pharmaceuticals
Calendar
02/25 | 01:30amEarnings Release
More about the company
Surperformance© ratings of Bayer AG
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER AG
02/09DJSanofi Profit Hit By Falling Diabetes Revenue -- Update
02/09DJSanofi Profit Hit By Falling Diabetes Revenue
02/09 BAYER : Continues to Grow its Open Innovation Activities
02/09DJSanofi Profit Hit By Falling Diabetes Revenue
02/09 BAYER : Continues to Grow its Open Innovation Activities
02/04 BAYER : reinforces its commitment to supporting partners along the food value ch..
02/04DJDeal Opens Path To China's Farms
02/03DJMerck Posts Lower Revenue and Profit -- 2nd Update
More news
Sector news : Pharmaceuticals - NEC
02:28a HIKMA PHARMACEUTICALS : *hsbc cuts hikma pharmaceuticals price target to 2525 pe..
01:33a GLAXOSMITHKLINE : *ubs raises glaxosmithkline price target to 1420 pence - 'neut..
01:16a NOVARTIS : Sandoz advances its biosimilars program with EMA acceptance of regula..
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on BAYER AG 
2015We anticipate a reversal
2014The EUR 100 area as entry point
More Strategies
News from SeekingAlpha
02/10 REGENERON DISAPPOINTS, THE STOCK SEL : Analysis Of Its Growth Potential
02/05 Upcoming Events - Bayer's Lung Cancer Effort And Apricus And Zealand Try Agai..
02/03 Nektar Therapeutics Going Into The Decline With A Better Profile
02/02 WisdomTree Europe Hedged Equity ETF (HEDJ) January Summary
02/01 Portola Pharma inks license and development deals in Japan for anti-coagulant..


Comments 
Advertisement
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions